Related Experiment Video
Updated: Apr 1, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Betatrophin in Diabetes Mellitus: the Epidemiological Evidence in Humans
Daniel Espes1,2, Mats Martinell3, Hanna Liljebäck4
1Department of Medical Cell Biology, Uppsala University, BMC, Husargatan 3, Box 571, Uppsala, SE-75123, Sweden. Daniel.Espes@mcb.uu.se.
Abstract:
The prevalence of type 2 diabetes is increasing worldwide, and while numerous treatments exist, none of the current pharmacologic therapies is curative. Pharmacologic approaches that increase beta cell mass may present an avenue for actual cure. There have been numerous reports on factors that can induce beta cell proliferation in rodents, whereas there are still very limited data on the occurrence of beta cell proliferation in humans. The recent discovery of the hormone betatrophin, which in mice counteracted glucose intolerance induced by insulin resistance by potently stimulating beta cell proliferation, has boosted the hope for a new target for drug development for the treatment of diabetes mellitus in humans. With the encouraging preclinical findings as a background, this review presents the available clinical data on betatrophin and discusses its possible role in humans.
Insights
Betatrophin, a hormone, shows promise for treating type 2 diabetes by stimulating beta cell proliferation. This review explores its potential role in humans, offering hope for a cure.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Diabetes Research
Background:
- Type 2 diabetes prevalence is rising globally, with current treatments lacking a cure.
- Increasing beta cell mass is a potential curative strategy for type 2 diabetes.
- Limited data exists on human beta cell proliferation compared to rodents.
Purpose of the Study:
- To review existing clinical data on the hormone betatrophin.
- To discuss the potential role of betatrophin in human diabetes treatment.
Main Methods:
- Literature review of preclinical and clinical studies on betatrophin.
- Analysis of betatrophin's effects on beta cell proliferation and glucose metabolism.
Main Results:
- Betatrophin demonstrated potent beta cell proliferation in mice.
- Preclinical findings suggest betatrophin counteracts insulin resistance-induced glucose intolerance.
Conclusions:
- Betatrophin represents a promising new target for diabetes drug development.
- Further clinical research is needed to validate betatrophin's efficacy and safety in humans.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Symptoms, Diagnosis, and Complications

